Article Information
History
- August 31, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- CN Mburu1,2,†,
- J Ojal1,2,
- R Chebet1,
- D Akech1,
- B Karia1,
- J Tuju1,
- A Sigilai1,
- K Abbas2,
- M Jit2,
- S Funk2,
- G Smits3,
- PGM van Gageldonk3,
- FRM van der Klis3,
- C Tabu4,
- DJ Nokes1,4,
- LSHTM CMMID COVID-19 Working Group,
- JAG Scott1,2,
- S Flasche2,* and
- IMO Adetifa1,2,*,†
- 1KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
- 2Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
- 3Department of Immunosurveillance, Centre for Infectious Diseases Control, National Institute of Public Health and the Environment (RIVM), The Netherlands
- 4National Vaccine and Immunisation Programme, Ministry of Health, Kenya
- 5School of Life Sciences and Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research (SBIDER), University of Warwick, Coventry, UK
- ↵† Corresponding author: Caroline Mburu, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. CMburu{at}kemri-wellcome.org, Alternate corresponding author; Ifedayo Adetifa KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. IAdetifa{at}kemri-wellcome.org
↵* these authors contributed equally, and their order was chosen at random
Posted August 31, 2020.
The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya
